Abstract

A key feature in intestinal immunity is the dynamic intestinal barrier, which separates the host from resident and pathogenic microbiota through a mucus gel impregnated with antimicrobial peptides. Using a forward genetic screen, we have found a mutation in Tvp23b, which conferred susceptibility to chemically induced and infectious colitis. Trans-Golgi apparatus membrane protein TVP23 homolog B (TVP23B) is a transmembrane protein conserved from yeast to humans. We found that TVP23B controls the homeostasis of Paneth cells and function of goblet cells, leading to a decrease in antimicrobial peptides and more penetrable mucus layer. TVP23B binds with another Golgi protein, YIPF6, which is similarly critical for intestinal homeostasis. The Golgi proteomes of YIPF6 and TVP23B-deficient colonocytes have a common deficiency of several critical glycosylation enzymes. TVP23B is necessary for the formation of the sterile mucin layer of the intestine and its absence disturbs the balance of host and microbe in vivo.

Increased susceptibility to gastrointestinal infections and colitis can be driven by a failure to maintain intestinal homeostasis. Here, using a forward genetic screen, Song et al. identify and characterise the role of TVP23B in Paneth cell and goblet cell function, and its impact on colitis.

Details

Title
Trans-Golgi protein TVP23B regulates host-microbe interactions via Paneth cell homeostasis and Goblet cell glycosylation
Author
Song, Ran 1   VIAFID ORCID Logo  ; McAlpine, William 1 ; Fond, Aaron M. 2   VIAFID ORCID Logo  ; Nair-Gill, Evan 1 ; Choi, Jin Huk 1   VIAFID ORCID Logo  ; Nyström, Elisabeth E. L. 3 ; Arike, Liisa 4   VIAFID ORCID Logo  ; Field, Sydney 5   VIAFID ORCID Logo  ; Li, Xiaohong 1 ; SoRelle, Jeffrey A. 6   VIAFID ORCID Logo  ; Moresco, James J. 1 ; Moresco, Eva Marie Y. 1   VIAFID ORCID Logo  ; Yates, John R. 7   VIAFID ORCID Logo  ; Azadi, Parastoo 8 ; Ni, Josephine 5 ; Birchenough, George M. H. 4   VIAFID ORCID Logo  ; Beutler, Bruce 1   VIAFID ORCID Logo  ; Turer, Emre E. 2   VIAFID ORCID Logo 

 University of Texas Southwestern Medical Center, Center for the Genetics of Host Defense, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 University of Texas Southwestern Medical Center, Center for the Genetics of Host Defense, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); University of Texas Southwestern Medical Center, Department of Internal Medicine, Division of Gastroenterology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 University of Kiel, Institute of Biochemistry, Kiel, Germany (GRID:grid.9764.c) (ISNI:0000 0001 2153 9986) 
 University of Gothenburg, The Wallenberg Centre for Molecular & Translational Medicine, Department of Medical Biochemistry, Institute of Biomedicine, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582) 
 University of Texas Southwestern Medical Center, Department of Internal Medicine, Division of Gastroenterology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 University of Texas Southwestern Medical Center, Center for the Genetics of Host Defense, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); University of Texas Southwestern Medical Center, Department of Pathology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 The Scripps Research Institute, Department of Molecular Medicine, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231) 
 University of Georgia, Complex Carbohydrate Research Center, Athens, USA (GRID:grid.213876.9) (ISNI:0000 0004 1936 738X) 
Pages
3652
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2827821882
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.